Delivery Order SPE2DB20D9329-SPE2DB23FZM29
Award Date 9/27/23
Potential Completion Date 9/28/23
Potential Value $1.3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Ketorolac Trometham, a pharmaceutical product, to the U.S. Defense Logistics Agency (DLA). The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $1,044.10 and a performance period ending on March 6, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $1,249.92, is for the supply of 30 mg/mL ketorolac injections. This award is part of a larger indefinite delivery contract (IDC) under the SPE2DB program, worth up to $499,999,999, which allows the DLA to issue delivery orders to DMS Pharmaceutical Group for a wide range of pharmaceutical...
- This federal contract award is a delivery order issued to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,225.46, is a firm fixed-price delivery order placed under the Defense Logistics Agency's (DLA) SPE2DB program, a $499,999,999 indefinite delivery contract that runs through December 31, 2025. Under this award, DMS Pharmaceutical Group will supply the DLA with the medication Ketorolac 30 mg/ml...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,044.10 firm-fixed-price delivery order is for the supply of Ketorolac Trometham, a pharmaceutical product. The contract has a performance period through March 13, 2025. It is not a set-aside contract. DMS Pharmaceutical Group Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a $7,395.36 firm fixed-price delivery order placed under the Defense Logistics Agency's (DLA) SPE2DB program. The order is for the supply of 4561901111 - KETOROLAC 30 MG/ML VIALML, a pharmaceutical product. The contract has an ultimate completion date of August 23, 2023 and does not utilize any set-aside designations. DMS Pharmaceutical Group is a key supplier of a wide range of pharmaceutical products...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,044.10 contract is for the supply of Ketorolac Trometham, a pain medication. DMS Pharmaceutical Group has a larger $499,999,999 Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, which allows DLA to issue delivery orders for a range of pharmaceutical products to support the medical supply...
- This is a $4,176.40 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which has a period of performance through March 3, 2025, is for the supply of Ketorolac Trometham, a non-steroidal anti-inflammatory drug. The contract is not set-aside and is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,051.65 award is for the delivery of Ketorolac 30 mg/mL vials, a pain medication, to support the recurring medical supply needs of military health facilities. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $1,173.04 under an indefinite delivery contract with the Defense Logistics Agency to supply the pharmaceutical item ketorolac tromethamine. The delivery order was awarded on October 29, 2019 with a completion date of November 8, 2019. No set-aside designation was used for this award. DMS Pharmaceutical Group will fulfill the delivery order from its place of performance in Park Ridge, Illinois. As a woman-owned...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $3,519.12 under an indefinite delivery contract with the Defense Logistics Agency to supply the pharmaceutical item ketorolac tromethamine. As a woman-owned small business, DMS Pharmaceutical Group will provide the requested product to Defense Logistics Agency Troop Support Medical facilities. DMS Pharmaceutical Group currently holds an indefinite delivery contract with the Defense Logistics Agency, valued at up...